(Q30361151)

20 June 2017

title

Inflammation modulation and cardiovascular disease prevention. (English)

1 reference

20 June 2017

0 references

cardiovascular disease

1 reference

2

Jacques Genest

1 reference

20 June 2017

Zuhier Awan

1

1 reference

20 June 2017

publication date

7 April 2014

1 reference

European Journal of Preventive Cardiology

20 June 2017

published in

1 reference

20 June 2017

volume

22

1 reference

20 June 2017

issue

6

1 reference

20 June 2017

page(s)

719-733

1 reference

Statins in cardiometabolic disease: what makes pitavastatin different?

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Major lipids, apolipoproteins, and risk of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised con

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Pathophysiology of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Chronic inflammatory diseases and cardiovascular risk: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Immune effector mechanisms implicated in atherosclerosis: from mice to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Primer: inflammasomes and interleukin 1beta in inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Canakinumab for the treatment of cryopyrin-associated periodic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Prospective study of inhaled corticosteroid use, cardiovascular mortality, and all-cause mortality in asthmatic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Incidence of arteriosclerosis in patients with rheumatoid arthritis receiving long-term corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Use of oral corticosteroids and the risk of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Aortic valve calcification in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Characterization of high molecular weight glycosylated forms of murine tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Does TNF-alpha blockade play any role in cardiovascular risk among rheumatoid arthritis (RA) patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

A novel mouse model that develops spontaneous arthritis and is predisposed towards atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Inflammatory mediators in chronic heart failure: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Clinical trials roundup in idiopathic inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Interleukin 6 destabilizes atherosclerotic plaques by downregulating prolyl-4-hydroxylase α1 via a mitogen-activated protein kinase and c-Jun pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: an open-label randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Vaccination strategies in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Inhibition of cholesterol atherosclerosis by immunisation with beta-lipoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Cardiovascular adverse effects of anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

Differential role and tissue specificity of interleukin-1α gene expression in atherogenesis and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529350

21 January 2018

Identifiers

DOI

10.1177/2047487314529350

1 reference

20 June 2017

1 reference